Is the flood of different COVID-19 serology tests bad news for clinical labs? Yes and no. Clinical laboratory managers and pathologists are well aware of the big undertaking it can be to select, validate, and implement a new COVID-19 serology test. The tests are brand new and abundant, and accuracy is an issue. But, a pro of these serology tests is the abundance of testing means an opportunity for financial gains, especially for labs with shelter-in-place orders since early March. ...
